rs371312567
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_000256.3(MYBPC3):c.407-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000283 in 1,552,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000256.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.407-5C>T | splice_region_variant, intron_variant | ENST00000545968.6 | NP_000247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.407-5C>T | splice_region_variant, intron_variant | 5 | NM_000256.3 | ENSP00000442795.1 | ||||
MYBPC3 | ENST00000399249.6 | c.407-5C>T | splice_region_variant, intron_variant | 5 | ENSP00000382193.2 | |||||
MYBPC3 | ENST00000544791.1 | n.407-5C>T | splice_region_variant, intron_variant | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000254 AC: 4AN: 157282Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 83226
GnomAD4 exome AF: 0.0000150 AC: 21AN: 1399902Hom.: 0 Cov.: 35 AF XY: 0.0000130 AC XY: 9AN XY: 690624
GnomAD4 genome AF: 0.000151 AC: 23AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74342
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Benign:2
Likely benign, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Dec 01, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 22, 2023 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 28, 2023 | Reported in association with hypertrophic cardiomyopathy (HCM) in published literature (Torrado et al., 2022); Observed in an individual referred for HCM genetic testing at GeneDx who had a different genetic etiology for the phenotype; In silico analysis supports that this variant does not alter splicing; This variant is associated with the following publications: (PMID: 28679633, 35508642) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2023 | The c.407-5C>T intronic variant results from a C to T substitution 5 nucleotides upstream from coding exon 4 in the MYBPC3 gene. One minigene splicing study suggests that this alteration may impact splicing, but technical limitations of the assay confound the interpretation (Ito K et al. Proc. Natl. Acad. Sci. U.S.A., 2017 07;114:7689-7694). This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jan 08, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at